Study Shows Highly Promising New Class Of Anti-Cancer Drugs
The New England Journal of Medicine has published a study today that shows stunning results of a new class of anti-cancer drugs known as PARP inhibitors. Scientists think this the class of drugs might be effective against breast, ovarian, and prostate cancers among others.